characteristics.text: SAMN47378028
characteristics.characteristic: External Id
characteristics.text: AstraZeneca
characteristics.characteristic: INSDC center name
characteristics.text: 2025-11-14T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-11-14T05:58:02.042Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS24361699
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS24361699
characteristics.characteristic: SRA accession
characteristics.text: 40Y
characteristics.characteristic: age
characteristics.text: Astrazeneca Oncology R&D, Cambridge, UK
characteristics.characteristic: biomaterial_provider
characteristics.text: SUM149PT
characteristics.characteristic: cell_line
characteristics.text: 2023-05-17
characteristics.characteristic: collection_date
characteristics.text: United Kingdom
characteristics.characteristic: geo_loc_name
characteristics.text: CVCL_3422
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Breast cancer
characteristics.characteristic: tissue
characteristics.text: Human sample from Homo sapiens
characteristics.characteristic: title
characteristics.text: saruparib-treated 1
characteristics.characteristic: treatment